IRIS
CALABRO', Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.688
NA - Nord America 12.275
AS - Asia 11.934
SA - Sud America 1.931
AF - Africa 185
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 52.039
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.773
US - Stati Uniti d'America 12.038
SG - Singapore 4.454
IE - Irlanda 2.473
CN - Cina 2.466
HK - Hong Kong 1.770
BR - Brasile 1.633
VN - Vietnam 1.591
IT - Italia 1.079
GB - Regno Unito 972
UA - Ucraina 886
DE - Germania 811
KR - Corea 445
FR - Francia 436
IN - India 365
FI - Finlandia 331
SE - Svezia 311
GR - Grecia 223
TR - Turchia 218
BD - Bangladesh 148
AR - Argentina 128
JP - Giappone 115
CA - Canada 102
AT - Austria 101
MX - Messico 88
ID - Indonesia 66
NL - Olanda 52
PL - Polonia 50
BE - Belgio 49
ZA - Sudafrica 48
IQ - Iraq 47
EC - Ecuador 46
PK - Pakistan 45
MA - Marocco 38
ES - Italia 33
EG - Egitto 31
CO - Colombia 30
VE - Venezuela 24
KE - Kenya 22
UZ - Uzbekistan 22
CL - Cile 21
LT - Lituania 20
SA - Arabia Saudita 19
UY - Uruguay 17
JO - Giordania 16
AE - Emirati Arabi Uniti 15
NP - Nepal 15
PE - Perù 15
PY - Paraguay 15
TH - Thailandia 15
TN - Tunisia 15
CH - Svizzera 14
IL - Israele 14
EU - Europa 12
IR - Iran 11
PH - Filippine 11
CR - Costa Rica 10
CZ - Repubblica Ceca 9
AL - Albania 8
JM - Giamaica 8
MY - Malesia 8
RS - Serbia 8
AU - Australia 7
AZ - Azerbaigian 7
KZ - Kazakistan 7
OM - Oman 7
RO - Romania 7
TW - Taiwan 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
DZ - Algeria 5
NO - Norvegia 5
PA - Panama 5
PT - Portogallo 5
AM - Armenia 4
BG - Bulgaria 4
EE - Estonia 4
ET - Etiopia 4
HN - Honduras 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
CI - Costa d'Avorio 3
GA - Gabon 3
GT - Guatemala 3
KG - Kirghizistan 3
MD - Moldavia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
Totale 52.006
Salva come PNG Salva come JPEG
Città #
Moscow 6.476
Dublin 2.454
Santa Clara 1.929
Singapore 1.837
San Jose 1.830
Hong Kong 1.744
Jacksonville 1.383
Chandler 1.101
Ashburn 634
Ho Chi Minh City 528
Hefei 505
Seoul 428
Hanoi 374
Princeton 362
Beijing 293
Roxbury 276
Medford 241
New York 231
Bengaluru 225
The Dalles 213
Boardman 199
Naples 175
Dallas 145
Wilmington 145
Bremen 138
Cambridge 132
Houston 131
Ann Arbor 124
Da Nang 123
São Paulo 123
Los Angeles 114
Nuremberg 111
Woodbridge 106
San Mateo 105
Helsinki 90
Des Moines 86
Council Bluffs 62
Milan 61
Nanjing 61
Haiphong 58
Munich 58
Rio de Janeiro 57
Falkenstein 53
Orem 50
Mountain View 49
Düsseldorf 48
Brussels 45
Rome 42
Belo Horizonte 38
Norwalk 37
Vienna 37
Curitiba 35
Guangzhou 35
Memphis 35
Tokyo 35
Frankfurt am Main 34
Brooklyn 32
Caserta 32
Mexico City 32
Aversa 31
Biên Hòa 31
Brasília 30
Chennai 28
London 28
Atlanta 27
Jinan 27
Shanghai 27
Amsterdam 26
Hải Dương 26
San Francisco 26
Johannesburg 25
Turku 25
Porto Alegre 24
Boston 23
Hyderabad 23
Thái Nguyên 23
Campinas 22
Ercolano 22
Lappeenranta 22
Montreal 22
Warsaw 22
Hangzhou 21
Ninh Bình 21
Philadelphia 21
Thái Bình 21
Tianjin 21
Toronto 21
Chicago 20
Columbus 20
Nanchang 20
Salvador 20
Istanbul 19
Nairobi 19
Tashkent 19
Baghdad 18
Bắc Ninh 18
Bến Tre 18
Changsha 18
Napoli 18
Nha Trang 18
Totale 27.068
Salva come PNG Salva come JPEG
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 239
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 221
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 187
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience 182
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 181
A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation 181
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 181
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 180
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy? 177
Advanced Heart Failure in Special Population—Pediatric Age 176
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 168
Adipose tissue and vascular inflammation in coronary artery disease. 167
. Accuratezza predittiva dell'elettrocardiogramma nell'identificazione dell'ipertrofia ventricolare sinistra. 167
Activated coagulation factor VII promotes smooth muscle cell proliferation in vitro. 167
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 164
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 163
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTalian cardiac care units Registry 162
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy 161
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 161
Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. 160
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 159
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 158
Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS 158
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 158
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions 156
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. 155
A new character on the scene of cardiorenal syndrome 154
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy 154
Natural history of left ventricular hypertrophy in infants of diabetic mothers 154
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 152
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 152
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 152
Association between left atrial myocardial function and exercise capacity in patients with either idiophatic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study 151
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? 151
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 151
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 150
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 150
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery Surgery After Stenting 2 149
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 149
. Left atrial strain/strain rate analylisis in patients with dilated cardiomyopathy. Correlation with clinical, electrocardiographic and echocardiographic findings 148
[The COMPASS study] 148
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) 147
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 147
. Plasma CT1 analysis in patients with hypertrophic cardiomyopathy. 146
Childhood obesity: An overview of laboratory medicine, exercise and microbiome 146
[Device therapy in chronic heart failure: a case of hypertrophic cardiomyopathy treated with cardiac contractility modulation therapy] 145
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 145
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 145
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 144
Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals 144
. L’analisi DMI del ventricolo destro a riposo predice la performance all’apice dello sforzo dei pazienti adulti operati per tetralogia di Fallot 144
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team 143
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials 142
Activated platelets stimulate tissue factor expression in smooth muscle cells 142
. Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle 142
.: Correlations between right ventricular myocardial function and cardiac performance during exercise in adult patients late after repair of tetralogy of Fallot 142
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 140
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 140
Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare. 138
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 137
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 137
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A contemporary reappraisal 137
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 136
Feasibility and usefulness of right ventricular ultrasonic tissue characterization with integrated backscatter in patients with unsuccessfully operatively "repaired" tetralogy of Fallot 134
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry) 134
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 133
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 133
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 133
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation 133
. Integrated backscatter analysis of functional and textural findings in young patients with different pathophysiological models of right ventricular overload 133
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target 132
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 132
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 131
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Impact of GEne Polymorphisms, Platelet REactivity and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 131
Obesità in età pediatrica ed ipertensione arteriosa 131
Registrazione del potenziale di azione monofasico e del recupero ventricolare a seguito di variazioni acute del sovraccarico di volume: evidenza in vivo del feedback elettromeccanico 131
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 131
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 131
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 131
New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention 130
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 130
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 130
Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives 129
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy 129
[Evaluation and percutaneous treatment of severely calcified coronary lesions] 129
Induction of tissue factor in the arterial wall during recurrent thrombus formation 128
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 128
De-escalation strategies in patients with acute coronary syndrome: a step towards precision medicine 128
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 127
[Debate on antiplatelet monotherapy: P2Y12 inhibitor monotherapy in patients with coronary artery disease] 127
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease 127
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 127
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 126
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 125
Effect of body mass index reduction on serum hepcidin levels and iron status in obese children 125
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 125
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 124
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 124
Hypertrophic cardiomyopathy in a girl with Cornelia de Lange syndrome due to mutation in SMC1A. 124
Totale 14.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.243
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/20222.391 130 13 26 82 785 27 36 148 86 184 147 727
2022/20234.257 452 145 58 348 401 307 10 206 2.136 32 78 84
2023/20242.109 144 59 76 161 680 223 86 74 12 57 155 382
2024/20257.551 26 74 35 213 1.164 1.071 1.092 614 956 1.186 644 476
2025/202631.281 1.110 1.504 1.635 1.545 2.349 16.660 1.920 1.546 1.220 971 553 268
Totale 53.038